Chronic Cough Clinical Trial
Official title:
Cough in Eastern and Central Finland
Verified date | February 2019 |
Source | Kuopio University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Comparison of citric acid and mannitol cough provocation tests among subjects with chronic cough and healthy volunteers.
Status | Completed |
Enrollment | 61 |
Est. completion date | January 31, 2019 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria, Chronic cough patients: (both criteria must be fulfilled) - presence of current chronic cough (> 8 weeks) - Leicester Cough Questionnaire total score < 17 Inclusion criteria, healthy volunteers - absence of any form of cough Exclusion Criteria: - age < 18 years - any disability which would challenge the subject's ability to understand the purpose and methods of the study - pregnancy - breastfeeding - current smoking or ex smoking more than 10 pack years - any thoracic x-ray finding indicating urgent mediacal interventions |
Country | Name | City | State |
---|---|---|---|
Finland | Kuopio University Hospital | Kuopio |
Lead Sponsor | Collaborator |
---|---|
Kuopio University Hospital | Helsinki University |
Finland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Receiver operator characteristic curves of the citric acid and the mannitol aerosol bronchial challenges | Receiver operator characteristic curve describes the ability of the bronchial challenge to separate the cough patients from healthy volunteers | Within one week from the start of the study in each individual | |
Secondary | Leicester Cough Questionnaire total score | Measures cough-spesific quality of life. Range is 3 - 21 with low total score indicating poor cough-spesific quality of life. The three Leicester Cough Questionnaire subscales are added together to form the total score. | The first study day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01432730 -
A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)
|
Phase 2 | |
Not yet recruiting |
NCT01413698 -
Cough Count Validation
|
N/A | |
Completed |
NCT03696108 -
A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)
|
Phase 3 | |
Recruiting |
NCT03638063 -
ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis
|
||
Recruiting |
NCT06376448 -
An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough
|
||
Completed |
NCT03172130 -
Sham CPAP vs. Straight CPAP for Chronic Cough
|
N/A | |
Recruiting |
NCT06286163 -
Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients
|
||
Completed |
NCT03622216 -
A Dose Escalation Study of Bradanicline in Refractory Chronic Cough
|
Phase 2 | |
Recruiting |
NCT05522699 -
Cough Suppressive Therapy in Patients With Chronic Cough
|
N/A | |
Completed |
NCT01297790 -
Cough Responses to Tussive Agents in Health and Disease
|
N/A | |
Completed |
NCT04193202 -
Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)
|
Phase 3 | |
Completed |
NCT01865422 -
French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL)
|
N/A | |
Completed |
NCT04525885 -
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension
|
Phase 3 | |
Completed |
NCT04193176 -
Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)
|
Phase 3 | |
Recruiting |
NCT05362097 -
Analysis of the Reliability and Validity of the Chinese Version of CC-QoL
|
||
Recruiting |
NCT03787511 -
Chronic Cough and Small Fiber Neuropathy
|
N/A | |
Terminated |
NCT03864328 -
A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF
|
Phase 2 | |
Completed |
NCT05274516 -
A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration
|
Phase 1 | |
Not yet recruiting |
NCT01807832 -
The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough.
|
N/A | |
Enrolling by invitation |
NCT05689307 -
Validation Study With a Non-CE Marked Medical Device (MD)
|
N/A |